Loxo Oncology, Inc.
DelistedCIK 1581720fmd_0RY2XBH01XETP3E268B67ZH8QDManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2013 to Sep 30, 2018, 20 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| Rental revenue | – | – | 0 | – |
| Total revenues | – | – | – | 0 |
| Net interest income | 0 | 0 | 1 | 4 |
| Research and development | 7 | 14 | 58 | 140 |
| Total operating expenses | – | 36 | 73 | 174 |
| Operating income | (21) | (36) | (73) | (152) |
| Income before taxes | (21) | (36) | (72) | – |
| Net income | (21) | (36) | (72) | (149) |
| Net income to common shareholders | (21) | (36) | (72) | (149) |